MYH11 and peripheral arterial disease: In accordance with the results that are presented in Figure 1, plasma myosin-11 levels were significantly higher in the CAD or PAD group (median (25th–75th percentiles): 84.6 (72.77–140.9) pg/mL) and the CAD + PAD group (median (25th–75th percentiles): 170.9 (152.8–238.0) pg/mL) than in control subjects (median (25th–75th percentiles): 27.5 (12.3–50.1) pg/mL) (Figure 2a).